| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.3 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |